New York: Taking a high dose of vitamin D could be an inexpensive and easy way to treat people with multiple sclerosis (MS), an autoimmune disorder that affects the brain and spinal chord, suggests promising new research.
"These results are exciting, as vitamin D has the potential to be an inexpensive, safe and convenient treatment for people with multiple sclerosis," said study author Peter Calabresi from Johns Hopkins University School of Medicine in the US.
Low levels of vitamin D in the blood are tied to an increased risk of developing MS and are more likely to have greater disability and more disease activity.
The current recommended daily allowance of vitamin D is 600 international units.
For the study, 40 people with relapsing-remitting MS received either 10,400 international units or 800 international units of vitamin D supplements per day for six months.
Patients with severe vitamin D deficiency were not included in the study.
Blood tests at the start of the study and again at three and six months measured the amount of vitamin D in the blood and the response in the immune system's T cells, which play a key role in MS.
While researchers are still determining the optimal level of vitamin D in the blood for people with MS, a suggested range of 40 to 60 nanograms per milliliter (ng/ml) has been proposed as a target.
Participants taking the high dose of vitamin D reached levels within the proposed target, whereas the group taking the low dose did not reach the target.
The people taking the high dose had a reduction in the percentage of inflammatory T cells related to MS severity.
Side effects from the vitamin supplements were minor and were not different between the people taking the high dose and the people taking the low dose, the study found.
The study was published online in the journal of Neurology.
"These results are exciting, as vitamin D has the potential to be an inexpensive, safe and convenient treatment for people with multiple sclerosis," said study author Peter Calabresi from Johns Hopkins University School of Medicine in the US.
Low levels of vitamin D in the blood are tied to an increased risk of developing MS and are more likely to have greater disability and more disease activity.
For the study, 40 people with relapsing-remitting MS received either 10,400 international units or 800 international units of vitamin D supplements per day for six months.
Advertisement
Blood tests at the start of the study and again at three and six months measured the amount of vitamin D in the blood and the response in the immune system's T cells, which play a key role in MS.
Advertisement
Participants taking the high dose of vitamin D reached levels within the proposed target, whereas the group taking the low dose did not reach the target.
Advertisement
Side effects from the vitamin supplements were minor and were not different between the people taking the high dose and the people taking the low dose, the study found.
Advertisement
COMMENTS
Advertisement
Selma Blair On Being Diagnosed With Multiple Sclerosis: "I Actually Became Much Happier" Vitamin D Supplements During Pregnancy: Understanding The Importance Former Boxer's Single Punch Results In UK Man's Permanent Brain Injury World's Largest Isolated Tribe Makes Rare Appearance In New Footage Barack Obama Wants Joe Biden To Pull Out Of US Presidential Race: Report Relationship Timeline Of Hardik Pandya, Wife Who "Parted Ways": 5 Facts NEET PG 2024: Test Cities Out For Postgraduate Medical Entrance Exam After 53 Years, Mortar Shells From 1971 Indo-Pak War Found In Fish Pond "Humanitarian Crisis Due To Israel-Hamas Conflict Concerning": India At UN Track Latest News Live on NDTV.com and get news updates from India and around the world.